EU Regulatory Status at a Glance:
  • Pre-Clinical
  • Phase 1
  • Phase 2
  • Phase 3
  • MAA Filed
  • Approved


Approved for Use

In 2018, AcelRx received approval for DZUVEO from the European Commission for use in medically monitored settings.

To learn more about DSUVIATM, the product's name in the U.S., please visit